Company intelligence / Profile preview

Hudson Bay Capital Management

Greenwich, Connecticut, USA

Ownership: Private
Employees: ~241
Development stage: Other

Overview

Not applicable; Hudson Bay Capital is an investment firm, not a drug R&D or clinical-stage company.

Industry: Investors

Partnerships

The firm frequently invests in healthcare/biotech companies but does not publicly disclose ongoing pharmaceutical or biotech development partnerships. It has been reported as a major shareholder in life science and SPAC (special purpose acquisition company) entities, and has been involved with companies like Reviva Pharmaceuticals, Aptevo Therapeutics, SELLAS Life Sciences, etc. through its investments.

Beyond the preview

Go deeper on Hudson Bay Capital Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hudson Bay Capital Management.

Explore the full profile